Overview

Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

Status:
Completed
Trial end date:
2020-02-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of itacitinib in combination with corticosteroids in Japanese subjects with Grades II to IV acute graft-versus-host disease (aGVHD).
Phase:
Phase 1
Details
Lead Sponsor:
Incyte Corporation